Matías Perrone Sibilia

Chronic infection with the protozoan Toxoplasma gondii prevents the development of experimental atopic dermatitis in mice.

S. Vanzulli, R. Moretta, Vanesa R. Sánchez, 2019, Journal of dermatological science.

Contribution of Kazal-Like Domains of the Serine Protease Inhibitor-1 from Toxoplasma gondii in Asthma Therapeutic Vaccination Effectiveness

Vanesa R. Sánchez, V. Martín, A. Goldman, 2022, International Archives of Allergy and Immunology.

Toxoplasma gondii serine-protease inhibitor-1: A new adjuvant candidate for asthma therapy

F. Polack, Vanesa R. Sánchez, V. Martín, 2017, PloS one.

Vaccine potential of antigen cocktails composed of recombinant Toxoplasma gondii TgPI-1, ROP2 and GRA4 proteins against chronic toxoplasmosis in C3H mice.

R. Moretta, Vanesa R. Sánchez, V. Martín, 2018, Experimental parasitology.

Synergistic effect of GRA7 and profilin proteins in vaccination against chronic Toxoplasma gondii infection.

R. Moretta, Vanesa R. Sánchez, V. Martín, 2021, Vaccine.